Cevec Pharmaceuticals GmbH

CEVEC is a global solution provider focusing on the development of top notch human expression systems with highest ethical standards. Our platform expression technologies CAP and CAP-T are based on specific, amniocyte derived human cell lines.
CAP and CAP-T are designed for stable and transient protein production and achieve highest protein yields with authentic human glycosylation patterns.
We have a high focus on research and development, production and marketing of our cell systems for protein and vaccine production accompanied by our development of selected “bio-better” and “bio-superior” candidates.